Global Biosimilar Drug Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Biosimilar Drug Market
The global Biosimilar Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Biosimilar Drug Scope and Segment
The global Biosimilar Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biosimilar Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Injection
Tablets
Other Types
By the end users/application, this report covers the following segments
Ankylosing Spondylitis
Tumor
Rheumatoid Arthrtis
Cardiovascular
Other Application
Competitive Landscape:
The report provides a list of all the key players in the Biosimilar Drug market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Biosimilar Drug key manufacturers in this market include:
CP Guojian Pharma
Biotech Pharma
Celgen Pharma
Henlius
Amgen
Eli Lilly
Sandoz
Changchun High Tech
Innovent

TABLE OF CONTENT

1 Biosimilar Drug Market Overview
1.1 Biosimilar Drug Product Overview
1.2 Biosimilar Drug Market Segment by Type
1.2.1 Injection
1.2.2 Tablets
1.2.3 Other Types
1.3 Global Biosimilar Drug Market Size by Type
1.3.1 Global Biosimilar Drug Market Size Overview by Type (2016-2027)
1.3.2 Global Biosimilar Drug Historic Market Size Review by Type (2016-2030)
1.3.2.1 Global Biosimilar Drug Sales Breakdown in Volume by Type (2016-2030)
1.3.2.2 Global Biosimilar Drug Sales Breakdown in Value by Type (2016-2030)
1.3.2.3 Global Biosimilar Drug Average Selling Price (ASP) by Type (2016-2030)
1.3.3 Global Biosimilar Drug Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Biosimilar Drug Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Biosimilar Drug Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Biosimilar Drug Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Biosimilar Drug Sales Breakdown by Type (2016-2030)
1.4.2 Europe Biosimilar Drug Sales Breakdown by Type (2016-2030)
1.4.3 Asia-Pacific Biosimilar Drug Sales Breakdown by Type (2016-2030)
1.4.4 Latin America Biosimilar Drug Sales Breakdown by Type (2016-2030)
1.4.5 Middle East and Africa Biosimilar Drug Sales Breakdown by Type (2016-2030)

2 Global Biosimilar Drug Market Competition by Company
2.1 Global Top Players by Biosimilar Drug Sales (2016-2030)
2.2 Global Top Players by Biosimilar Drug Revenue (2016-2030)
2.3 Global Top Players Biosimilar Drug Price (2016-2030)
2.4 Global Top Manufacturers Biosimilar Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Biosimilar Drug Market Competitive Situation and Trends
2.5.1 Biosimilar Drug Market Concentration Rate (2016-2030)
2.5.2 Global 5 and 10 Largest Manufacturers by Biosimilar Drug Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biosimilar Drug as of 2020)
2.7 Date of Key Manufacturers Enter into Biosimilar Drug Market
2.8 Key Manufacturers Biosimilar Drug Product Offered
2.9 Mergers & Acquisitions, Expansion

3 Biosimilar Drug Status and Outlook by Region
3.1 Global Biosimilar Drug Market Size and CAGR by Region: 2016 VS 2030 VS 2026
3.2 Global Biosimilar Drug Historic Market Size by Region
3.2.1 Global Biosimilar Drug Sales in Volume by Region (2016-2030)
3.2.2 Global Biosimilar Drug Sales in Value by Region (2016-2030)
3.2.3 Global Biosimilar Drug Sales (Volume & Value) Price and Gross Margin (2016-2030)
3.3 Global Biosimilar Drug Forecasted Market Size by Region
3.3.1 Global Biosimilar Drug Sales in Volume by Region (2022-2027)
3.3.2 Global Biosimilar Drug Sales in Value by Region (2022-2027)
3.3.3 Global Biosimilar Drug Sales (Volume & Value), Price and Gross Margin (2022-2027)

4 Global Biosimilar Drug by Application
4.1 Biosimilar Drug Market Segment by Application
4.1.1 Ankylosing Spondylitis
4.1.2 Tumor
4.1.3 Rheumatoid Arthrtis
4.1.4 Cardiovascular
4.1.5 Other Application
4.2 Global Biosimilar Drug Market Size by Application
4.2.1 Global Biosimilar Drug Market Size Overview by Application (2016-2027)
4.2.2 Global Biosimilar Drug Historic Market Size Review by Application (2016-2030)
4.2.2.1 Global Biosimilar Drug Sales Breakdown in Volume, by Application (2016-2030)
4.2.2.2 Global Biosimilar Drug Sales Breakdown in Value, by Application (2016-2030)
4.2.2.3 Global Biosimilar Drug Average Selling Price (ASP) by Application (2016-2030)
4.2.3 Global Biosimilar Drug Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Biosimilar Drug Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Biosimilar Drug Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Biosimilar Drug Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Biosimilar Drug Sales Breakdown by Application (2016-2030)
4.3.2 Europe Biosimilar Drug Sales Breakdown by Application (2016-2030)
4.3.3 Asia-Pacific Biosimilar Drug Sales Breakdown by Application (2016-2030)
4.3.4 Latin America Biosimilar Drug Sales Breakdown by Application (2016-2030)
4.3.5 Middle East and Africa Biosimilar Drug Sales Breakdown by Application (2016-2030)

5 North America Biosimilar Drug by Country
5.1 North America Biosimilar Drug Historic Market Size by Country
5.1.1 North America Biosimilar Drug Sales in Volume by Country (2016-2030)
5.1.2 North America Biosimilar Drug Sales in Value by Country (2016-2030)
5.2 North America Biosimilar Drug Forecasted Market Size by Country
5.2.1 North America Biosimilar Drug Sales in Volume by Country (2022-2027)
5.2.2 North America Biosimilar Drug Sales in Value by Country (2022-2027)

6 Europe Biosimilar Drug by Country
6.1 Europe Biosimilar Drug Historic Market Size by Country
6.1.1 Europe Biosimilar Drug Sales in Volume by Country (2016-2030)
6.1.2 Europe Biosimilar Drug Sales in Value by Country (2016-2030)
6.2 Europe Biosimilar Drug Forecasted Market Size by Country
6.2.1 Europe Biosimilar Drug Sales in Volume by Country (2022-2027)
6.2.2 Europe Biosimilar Drug Sales in Value by Country (2022-2027)

7 Asia-Pacific Biosimilar Drug by Region
7.1 Asia-Pacific Biosimilar Drug Historic Market Size by Region
7.1.1 Asia-Pacific Biosimilar Drug Sales in Volume by Region (2016-2030)
7.1.2 Asia-Pacific Biosimilar Drug Sales in Value by Region (2016-2030)
7.2 Asia-Pacific Biosimilar Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Biosimilar Drug Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Biosimilar Drug Sales in Value by Region (2022-2027)

8 Latin America Biosimilar Drug by Country
8.1 Latin America Biosimilar Drug Historic Market Size by Country
8.1.1 Latin America Biosimilar Drug Sales in Volume by Country (2016-2030)
8.1.2 Latin America Biosimilar Drug Sales in Value by Country (2016-2030)
8.2 Latin America Biosimilar Drug Forecasted Market Size by Country
8.2.1 Latin America Biosimilar Drug Sales in Volume by Country (2022-2027)
8.2.2 Latin America Biosimilar Drug Sales in Value by Country (2022-2027)

9 Middle East and Africa Biosimilar Drug by Country
9.1 Middle East and Africa Biosimilar Drug Historic Market Size by Country
9.1.1 Middle East and Africa Biosimilar Drug Sales in Volume by Country (2016-2030)
9.1.2 Middle East and Africa Biosimilar Drug Sales in Value by Country (2016-2030)
9.2 Middle East and Africa Biosimilar Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Biosimilar Drug Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Biosimilar Drug Sales in Value by Country (2022-2027)

10 Company Profiles and Key Figures in Biosimilar Drug Business
10.1 CP Guojian Pharma
10.1.1 CP Guojian Pharma Corporation Information
10.1.2 CP Guojian Pharma Introduction and Business Overview
10.1.3 CP Guojian Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2016-2030)
10.1.4 CP Guojian Pharma Biosimilar Drug Products Offered
10.1.5 CP Guojian Pharma Recent Development
10.2 Biotech Pharma
10.2.1 Biotech Pharma Corporation Information
10.2.2 Biotech Pharma Introduction and Business Overview
10.2.3 Biotech Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2016-2030)
10.2.4 Biotech Pharma Biosimilar Drug Products Offered
10.2.5 Biotech Pharma Recent Development
10.3 Celgen Pharma
10.3.1 Celgen Pharma Corporation Information
10.3.2 Celgen Pharma Introduction and Business Overview
10.3.3 Celgen Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2016-2030)
10.3.4 Celgen Pharma Biosimilar Drug Products Offered
10.3.5 Celgen Pharma Recent Development
10.4 Henlius
10.4.1 Henlius Corporation Information
10.4.2 Henlius Introduction and Business Overview
10.4.3 Henlius Biosimilar Drug Sales, Revenue and Gross Margin (2016-2030)
10.4.4 Henlius Biosimilar Drug Products Offered
10.4.5 Henlius Recent Development
10.5 Amgen
10.5.1 Amgen Corporation Information
10.5.2 Amgen Introduction and Business Overview
10.5.3 Amgen Biosimilar Drug Sales, Revenue and Gross Margin (2016-2030)
10.5.4 Amgen Biosimilar Drug Products Offered
10.5.5 Amgen Recent Development
10.6 Eli Lilly
10.6.1 Eli Lilly Corporation Information
10.6.2 Eli Lilly Introduction and Business Overview
10.6.3 Eli Lilly Biosimilar Drug Sales, Revenue and Gross Margin (2016-2030)
10.6.4 Eli Lilly Biosimilar Drug Products Offered
10.6.5 Eli Lilly Recent Development
10.7 Sandoz
10.7.1 Sandoz Corporation Information
10.7.2 Sandoz Introduction and Business Overview
10.7.3 Sandoz Biosimilar Drug Sales, Revenue and Gross Margin (2016-2030)
10.7.4 Sandoz Biosimilar Drug Products Offered
10.7.5 Sandoz Recent Development
10.8 Changchun High Tech
10.8.1 Changchun High Tech Corporation Information
10.8.2 Changchun High Tech Introduction and Business Overview
10.8.3 Changchun High Tech Biosimilar Drug Sales, Revenue and Gross Margin (2016-2030)
10.8.4 Changchun High Tech Biosimilar Drug Products Offered
10.8.5 Changchun High Tech Recent Development
10.9 Innovent
10.9.1 Innovent Corporation Information
10.9.2 Innovent Introduction and Business Overview
10.9.3 Innovent Biosimilar Drug Sales, Revenue and Gross Margin (2016-2030)
10.9.4 Innovent Biosimilar Drug Products Offered
10.9.5 Innovent Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Biosimilar Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Biosimilar Drug Industrial Chain Analysis
11.4 Biosimilar Drug Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints

12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Biosimilar Drug Distributors
12.3 Biosimilar Drug Downstream Customers

13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

Choose License Type

Checkout Inquiry Sample